All it took....was someone from big pharma to say to the wrong person is <The PharmaGap has some interesting findings from NCI, we may have to looking into that some more> And all of a sudden, word spread, and GAP is a BUY, although we (the Board) have considered it a buy, and see it as huge potential, but larger investors don't do as deep of Due Dilligence when picking these companies.
TFSATrader.